BRIDGEWAY CAPITAL MANAGEMENT, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2018$124,000
-75.7%
109,800
-40.6%
0.00%
-60.0%
Q3 2018$510,000
+78.9%
184,800
+131.6%
0.01%
+66.7%
Q2 2018$285,000
+16.3%
79,8000.0%0.00%0.0%
Q1 2018$245,000
-51.3%
79,8000.0%0.00%
-40.0%
Q4 2017$503,000
-7.9%
79,8000.0%0.01%
-16.7%
Q3 2017$546,000
-4.0%
79,8000.0%0.01%
-14.3%
Q2 2017$569,000
-60.0%
79,800
-48.4%
0.01%
-58.8%
Q1 2017$1,423,000
+25.7%
154,800
-44.9%
0.02%
+13.3%
Q4 2016$1,132,000
+5.2%
280,9000.0%0.02%
-6.2%
Q3 2016$1,076,000
-30.8%
280,900
-22.3%
0.02%
-33.3%
Q2 2016$1,555,000
+29.0%
361,717
+1324.1%
0.02%0.0%
Q2 2015$1,205,000
-34.2%
25,400
-49.2%
0.02%
-36.8%
Q1 2015$1,832,000
-7.8%
50,0000.0%0.04%
-15.6%
Q4 2014$1,986,000
+99.0%
50,0000.0%0.04%
+80.0%
Q3 2014$998,000
+47.9%
50,0000.0%0.02%
+38.9%
Q2 2014$675,00050,0000.02%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,048,642$3,219,0000.50%
Virtus ETF Advisers LLC 130,920$402,0000.35%
683 Capital Management, LLC 600,000$1,842,0000.16%
Tekla Capital Management LLC 859,322$2,638,0000.10%
DOW CHEMICAL CO /DE/ 65,000$200,0000.07%
Alambic Investment Management, L.P. 115,834$356,0000.05%
A.R.T. Advisors, LLC 262,896$807,0000.03%
Candriam S.C.A. 520,613$1,598,0000.03%
Man Group plc 1,674,341$5,140,0000.02%
Baker Brothers Advisors 935,000$2,870,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders